Total planned funding: $362,077,954
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $362,077,954 |
Organizational Types
NGO | $97,303,505 |
Private Contractor | $65,072,148 |
Own Agency | $52,330,454 |
Unknown | $45,607,751 |
University | $41,300,597 |
Host Country Government Agency | $39,208,927 |
Parastatal | $8,970,169 |
Implementing Agency | $5,883,577 |
Multi-lateral Agency | $3,010,195 |
Other USG Agency | $2,630,631 |
FBO | $760,000 |
Program Areas
Treatment | $100,986,567 |
Prevention | $79,805,633 |
Care | $73,511,859 |
Governance and Systems | $44,246,398 |
Management and Operations | $34,182,153 |
Testing | $29,345,344 |
Budget Codes
HTXS: Treatment: Adult Treatment | $82,799,088 |
HVMS: Management and Operations | $34,182,153 |
HVCT: Testing: HIV Testing and Counseling | $29,345,344 |
HKID: Care: Orphans and Vulnerable Children | $26,930,194 |
HBHC: Care: Adult Care and Support | $26,077,409 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $22,197,094 |
OHSS: Health Systems Strengthening | $19,265,120 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $19,186,960 |
HVSI: Strategic Information | $19,078,209 |
HVOP: Sexual Prevention: Other Sexual Prevention | $18,722,615 |
HVTB: Care: TB/HIV | $12,200,825 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,541,709 |
PDTX: Treatment: Pediatric Treatment | $9,832,778 |
HTXD: Treatment: ARV Drugs | $8,354,701 |
PDCS: Care: Pediatric Care and Support | $8,303,431 |
HLAB: Laboratory Infrastructure | $5,903,069 |
HMBL: Biomedical Prevention: Blood Safety | $4,925,217 |
HMIN: Biomedical Prevention: Injection Safety | $3,232,038 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$38,745,399
Countries/Regions
Not Available:
$38,266,929
Countries/Regions
USG Aggregated Agencies:
$34,508,405
Countries/Regions
University of Washington:
$27,284,300
Countries/Regions